Linda G Griffith

Cambridge, MA, United States of America

Linda G Griffith

USPTO Granted Patents = 21 


 

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 952(Granted Patents)


Company Filing History:


Years Active: 2000-2024

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Linda G. Griffith in Biotechnology

Introduction: Linda G. Griffith, based in Cambridge, MA, stands as a prominent figure in the field of biotechnology, holding an impressive portfolio of 21 patents. Her pioneering work reflects a deep commitment to advancing medical technology and enhancing our understanding of biological processes.

Latest Patents: Among her notable patents, Griffith has developed "Synthetic Hydrogels for Organogenesis," designed to support organogenesis from mammalian cells, including human cells. These synthetic hydrogels feature a network of crosslinked branched biodegradable polymers, facilitating cell and extracellular matrix attachment through synthetic peptides. Additionally, they may contain inhibitors of apoptosis and are engineered for on-demand dissolution, allowing for intact organoids free from hydrogel polymers. Another significant patent is the "Modular Organ Microphysiological System with Integrated Pumping, Leveling, and Sensing," which serves as a microphysiological platform for the in vitro investigation of multi-organ interactions over extended periods. This platform includes innovative features like on-board pneumatic fluid pumping, a self-leveling spillway, and built-in fluid level sensing devices, thus supporting a wide range of biomedical applications, including systemic toxicity studies.

Career Highlights: Linda G. Griffith has made substantial contributions to the field through her work at renowned organizations. Notably, she has been associated with the Massachusetts Institute of Technology and Children's Medical Center Corporation, where her research has pushed the boundaries of what is possible in organ engineering and tissue regeneration.

Collaborations: Griffith has collaborated with leading scientists, including Steven R. Tannenbaum and Samuel Walker Inman. These collaborations have fostered innovation and broadened the scope of her research, resulting in impactful advancements in biomedicine.

Conclusion: Linda G. Griffith's dedication to innovation in biotechnology is evident through her extensive patent portfolio and collaborative efforts. Her contributions not only enhance scientific understanding but also hold the potential for significant improvements in medical treatments and therapies, reaffirming her status as a leader in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…